Slide 1 1 Buprenorphine in the Treatment of Opioid Addiction: Balancing Medication Access with Quality Care Opening Remarks February 21, 2008 H. Westley Clark, M.D., J.D.,…
Slide 1 Slide 2 MEDICATION ASSISTED TREATMENT for OPIATE DEPENDENCY WHAT WORKS? SHELLEY ASKEW FLOYD, MS DIRECTOR OF PHARMACOTHERAPY SERVICES PYRAMID HEALTHCARE, INC. 1 Slide…
November 12, 2012 Buprenorphine and Related Dynamics in a Clinical Setting Dean Babcock, MSW, LCSW, LCAC Associate Vice President Midtown Community Mental Health Center High…
American Association for the Treatment of Opioid Dependence, Inc. 2006 National Conference, Atlanta April 25, 2006 Evaluation of the Impact of Opioid Treatment Program (OTP)…
Prim. mag. Marija Cesar Komar dr.med. 1st Congress of the Slovenian Association for Pain Therapy and Symposium on Clinical Neurophysiology of Pain Bled, 9-10 October 2009…
CTN Pharmacotherapy Trials and the CTP Allan J. Cohen, MA, MFT Bay Area Addiction, Research and Treatment, Inc (BAART) Pacific Region Node CTN 10th Anniversary Symposium…
Long Acting Opioids: Challenges in Pharmacotherapy Mary Jeanne Kreek, M.D. The Laboratory of the Biology of Addictive Diseases The Rockefeller University September 10, 2003…
PowerPoint Presentation Larry Wolf, chair Marc Probst, co-chair Certification / Adoption Workgroup February 7, 2014 0 Agenda Review of Agenda Workforce Subgroup â Update…
The Psychological and Physical Side Effects of Pain Medications BY: DONALD TEATER, M.D. Medical Advisor, National Safety Council 2 The Psychological and Physical Side-effects…